Growth, Innovation Could Fuel Pharma ETF Rebound

For much of 2020 and 2021, the pharmaceutical stock investment thesis revolved around development and disbursement of coronavirus vaccines. While that made for an obvious catalyst, and a rewarding one at that, the effects of the COVID-19 vaccine status as an accelerant for pharma equities waned this year. Fortunately, exchange traded funds such as the [...] The post Growth, Innovation Could Fuel Pharma ETF Rebound appeared first on ETF Trends .